Additionally, METTL3 stabilises OTUB1 mRNA in a PKP3‐dependent manner, enhancing the efficacy of anti‐PD‐1 therapy in NSCLC.37 This evidence concerns the gene METTL3 and non-small cell lung carcinoma.